secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAGENICS INC (OGEN)
CIK:        0001174940
Form:       8-K
Filed at:   2023-12-08T23:59:59+00:00
Accession:  0001493152-23-044220
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oragenics designates 8M Series F Convertible Preferred Stock for Odyssey asset purchase
--------------------------------------------------------------------------------

- Filed Certificate of Designation for 8,000,000 shares of Series F Convertible Preferred Stock for the Odyssey Health asset purchase.
- Series F is economically equivalent to common stock; liquidation junior to Class A, B, and Series E Preferred; no dividends, no voting rights.
- Converts 1:1 into common stock upon close of Odyssey purchase, subject to shareholder approval for issuance and 350M authorized share increase.
- Conversion capped at 19.9% of outstanding common stock until NYSE American listing or delisting and change-of-control approval if needed.
- Redemption not permitted; no trading market expected; preemptive rights not provided.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1174940/000149315223044220/0001493152-23-044220-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1174940/000149315223044220/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-044220

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer